A first-of-its-kind clinical trial has shown that ketamine infusions, combined with psychotherapy, is more effective in helping people suffering from severe alcoholism avoid relapse than any other current treatment.

Source of Article

People with hypertension often have to perform arm-cuff blood pressure readings multiple times per day. Not only is this a hassle, but it may not provide a complete picture of their problem – that's where the always-on Aktiia wearable comes in.

Source of Article

Israel has begun the world’s first roll-out of a fourth COVID-19 vaccine dose. The program is initially focusing on patients with compromised immune systems, while a study is underway testing the safety and efficacy of a fourth dose in 6,000 people.

Source of Article

The FDA issued emergency use authorization to a second oral COVID-19 treatment. Molnupiravir is not as effective as Pfizer’s recently approved COVID pill and experts are concerned the drug has the potential to generate new SARS-CoV-2 variants.

Source of Article

A new report from the Centers for Disease Control and Prevention indicates the Omicron variant is now dominant in the United States. The CDC’s variant-tracking model found Omicron has skyrocketed in prevalence over the course of two to three weeks.

Source of Article

Positive data has been announced from a trial testing Pfizer’s antiviral pill developed to treat COVID-19. The final analysis revealed the five-day oral treatment reduced COVID-related hospitalizations and deaths by 89 percent in high-risk individuals.

Source of Article

The FDA has authorized the first COVID-19 drug designed to prevent infection in immunocompromised populations. The monoclonal antibody treatment is delivered by intramuscular injection and offers robust protection from infection for up to six months.

Source of Article

New data indicates two doses of Pfizer and BioNTech's COVID-19 vaccine may not be sufficient to protect from the Omicron variant. However, a third dose was seen to raise antibody levels to those seen with two doses against the original coronavirus.

Source of Article

Nicotine is one of the more harmful compounds in electronic cigarette vapor, so non-vapers should avoid breathing it in whenever possible. A new skin-worn sensor could help, by monitoring airborne nicotine levels in the wearer's immediate vicinity.

Source of Article

As drugmakers race to understand how effective current COVID-19 vaccines may be against the new Omicron variant, Novavax has announced it anticipates the ability to begin mass manufacturing an Omicron-specific vaccine as soon as January next year.

Source of Article